Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Debt Ratio (2020 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Debt Ratio for 8 consecutive years, with 0.22 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 34.89% year-over-year to 0.22, compared with a TTM value of 0.22 through Dec 2025, down 34.89%, and an annual FY2025 reading of 0.22, down 34.89% over the prior year.
  • Debt Ratio was 0.22 for Q4 2025 at Zevra Therapeutics, down from 0.23 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.4 in Q2 2024 and bottomed at 30.05 in Q2 2022.
  • Average Debt Ratio over 5 years is 1.81, with a median of 0.23 recorded in 2025.
  • The sharpest move saw Debt Ratio skyrocketed 742.47% in 2024, then tumbled 41.37% in 2025.
  • Year by year, Debt Ratio stood at 0.01 in 2021, then skyrocketed by 1185.04% to 0.11 in 2022, then soared by 123.62% to 0.25 in 2023, then skyrocketed by 34.61% to 0.33 in 2024, then tumbled by 34.89% to 0.22 in 2025.
  • Business Quant data shows Debt Ratio for ZVRA at 0.22 in Q4 2025, 0.23 in Q3 2025, and 0.24 in Q2 2025.